This educational activity is designed for gastroenterologists, endocrinologists, surgeons, internists, clinical researchers, physician assistants, nurses and other healthcare providers involved and/or interested in the diagnosis, treatment, and management of patients with infl ammatory bowel disease (IBD).
Learning Objectives Upon completion of this activity, participants should be able to:
- Comment on signifi cant advances in IBD therapeutic options regarding the use of biologics and immunomodulators
- Review state-of-the-art endoscopic and surgical techniques
- Assess advantages and disadvantages of current pharmacological therapies for IBD
- Discuss emerging genomic research developments in IBD
- Describe evolving patient management and treatment strategies for complications in IBD, both intra- and extra-intestinal
- Comment on the recommendations in IBD for optimal cancer surveillance
- Review the optimal strategy options for the management of pediatric and adolescent patients
- Discuss the most recent ECCO recommendations on vaccination in IBD patient populations
- Improve patient care and disease management options based on case presentations led by clinical experts in IBD
